Back to results
US 2025/0025449 A1Published application
Methods and compositions for treatment of epileptic disorders
AssigneeOvid Therapeutics Inc.
InventorMatthew During
Life of this patent
Estimating the term…
Abstract
Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.
Claims22
A method for treatment of seizures associated with CDKL5 deficiency disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising about 50 mg/mL ganaxolone in a dosage regimen that comprises administering the pharmaceutical composition three times a day.
Dependencies are inferred from the claim text.